Enhancing California’s Manufacturing of Leading-Edge Cell & Gene Therapies
Grant Award Details
Grant Type:
Grant Number:
INFR5-14739
Investigator(s):
Award Value:
$2,000,000
Status:
Active
Grant Application Details
Application Title:
Enhancing California’s Manufacturing of Leading-Edge Cell & Gene Therapies
Public Abstract:
We will implement a new staffing model, training regimen, electronic quality management system, and outreach activities to overcome current bottlenecks and provide the foundation for manufacturing the pipeline of cell and gene therapies under development to bring treatments and cures to patients.
Statement of Benefit to California:
This project tackles current bottlenecks in manufacturing for cell and gene therapies and expands capacity and capabilities to address the growing pipeline. This positions our GMP to play an active role in the development and exchange of best practices and know-how across a network of GMPs in California. In addition to creating new jobs in the California economy, these efforts will ensure that the most promising new treatments and cures reach the patients in California who need them most.